Atezolizumab Combined With Immunogenic Chemotherapy in Patients With Metastatic Triple-negative Breast Cancer
Clinical trial NCT03164993 · COMPLETED
Trial details
- NCT number
- NCT03164993
- Sponsor
- Oslo University Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-01
- Primary completion
- 2023-04-25
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.